Literature DB >> 12114804

Overview of Neuroendocrine Cells and Tumors.

Ricardo V. Lloyd1.   

Abstract

The diffuse neuroendocrine system (DNES) is composed of cells and tumors with secretory granules ranging from 50-400 nm in diameter. Members of the DNES commonly stain for chromogranin and synaptophysin by immunohistochemistry and may express a variety of peptide hormones. Recent studies have shown that the proprotein convertases (proconvertases or PCs) are good broad-spectrum markers for members of the DNES. Gene expression can be readily detecting in neuroendocrine cells and tumors by in situ hybridization (ISH). Newer techniques such as in situ polymerase chain reaction (PCR) can be used to detect gene products that are expressed in low copy numbers in neuroendocrine cells. The concept of multidirectional differentiation is an important notion that helps to explain multiple patterns of phenotypic expression observed in some neuroendocrine tumors.

Entities:  

Year:  1996        PMID: 12114804     DOI: 10.1007/bf02739840

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  22 in total

1.  New techniques in gene product analysis.

Authors:  R A DeLellis; H J Wolfe
Journal:  Arch Pathol Lab Med       Date:  1987-07       Impact factor: 5.534

2.  Comparison of indirect and direct in-situ polymerase chain reaction in cell preparations and tissue sections. Detection of viral DNA, gene rearrangements and chromosomal translocations.

Authors:  A A Long; P Komminoth; E Lee; H J Wolfe
Journal:  Histochemistry       Date:  1993-02

Review 3.  Classification of normal and neoplastic neuroendocrine cells.

Authors:  G Klöppel; P U Heitz
Journal:  Ann N Y Acad Sci       Date:  1994-09-15       Impact factor: 5.691

4.  Goblet cell carcinoid of the appendix.

Authors:  F H Rodriguez; D P Sarma; J H Lunseth
Journal:  Hum Pathol       Date:  1982-03       Impact factor: 3.466

5.  Carcinoma of the thyroid with a mixed medullary and follicular pattern: morphologic, immunohistochemical, and clinical laboratory studies.

Authors:  M Hales; W Rosenau; M D Okerlund; M Galante
Journal:  Cancer       Date:  1982-10-01       Impact factor: 6.860

6.  Variation in cellular EGF receptor mRNA expression demonstrated by in situ reverse transcriptase polymerase chain reaction.

Authors:  B W Heniford; A Shum-Siu; M Leonberger; F J Hendler
Journal:  Nucleic Acids Res       Date:  1993-07-11       Impact factor: 16.971

Review 7.  Multidirectional differentiation in neuroendocrine neoplasms.

Authors:  R A DeLellis; A S Tischler; H J Wolfe
Journal:  J Histochem Cytochem       Date:  1984-08       Impact factor: 2.479

Review 8.  Chromogranin A.

Authors:  G N Hendy; S Bevan; M G Mattei; A J Mouland
Journal:  Clin Invest Med       Date:  1995-02       Impact factor: 0.825

9.  Proprotein convertases (PC1/PC3 and PC2) in normal and neoplastic human tissues: their use as markers of neuroendocrine differentiation.

Authors:  L Scopsi; M Gullo; F Rilke; S Martin; D F Steiner
Journal:  J Clin Endocrinol Metab       Date:  1995-01       Impact factor: 5.958

10.  Ductuloinsular tumors of the pancreas: a light, electron microscopic and immunohistochemical study.

Authors:  J D Reid; S L Yuh; M Petrelli; R Jaffe
Journal:  Cancer       Date:  1982-03-01       Impact factor: 6.860

View more
  3 in total

Review 1.  C-cell hyperplasia and medullary thyroid microcarcinoma.

Authors:  J A Albores-Saavedra; J E Krueger
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

2.  Small cell neuroendocrine carcinoma of nose and paranasal sinuses: a study of three cases with short review of the literature.

Authors:  D N Chatterjee; Asitava Mondal
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2009-03-31

3.  Insulin and Glucagon mRNA Expression and Prohormone Convertase Immunoreactivity in Normal and Neoplastic Pancreatic Endocrine Tissue.

Authors:  Mark Rodacker; Long Jin; Shuga Zhang; Ricardo V. Lloyd
Journal:  Endocr Pathol       Date:  2000       Impact factor: 3.943

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.